Medtronic announced the results of a new "real-world" study of patients who have had a cryptogenic stroke, in which the Reveal Linq Insertable Cardiac Monitor (ICM) detected atrial fibrillation (AF) in everyday practice at an even greater rate than that found in a recent clinical trial (the CRYSTAL AF Study, which was published in The New England Journal of Medicine).
